tryptophan and Autosomal Dominant Cerebellar Ataxia, Type II

tryptophan has been researched along with Autosomal Dominant Cerebellar Ataxia, Type II in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adanyeguh, I; Collins, B; Durr, A; Evans, RM; Fan, W; Ichou, F; Kinoshita, C; La Spada, AR; Mochel, F; Morrison, RS; Muotri, AR; Niu, C; Sopher, BL; Stoyas, CA; Switonski, PM; Wall, CE; Ward, JM1

Other Studies

1 other study(ies) available for tryptophan and Autosomal Dominant Cerebellar Ataxia, Type II

ArticleYear
Metabolic and Organelle Morphology Defects in Mice and Human Patients Define Spinocerebellar Ataxia Type 7 as a Mitochondrial Disease.
    Cell reports, 2019, 01-29, Volume: 26, Issue:5

    Topics: Adipose Tissue; Animals; Ataxin-7; Blood Glucose; Energy Metabolism; Humans; Kynurenine; Metabolomics; Mice; Mitochondria; Mitochondrial Diseases; NAD; Neural Stem Cells; Organelles; Peptides; Phenotype; Purkinje Cells; Reproducibility of Results; Spinocerebellar Ataxias; Trinucleotide Repeat Expansion; Tryptophan

2019